TherapeuticsMD, Inc. (NYSEMKT:TXMD) Files An 8-K Regulation FD Disclosure
Item 7.01.
| Regulation FD Disclosure. |
TherapeuticsMD, Inc. is furnishing as Exhibit 99.1 to this
Current Report on Form 8-K an investor presentation which will be
used, in whole or in part, and subject to modification, on
January 9, 2017 and at subsequent meetings with investors or
analysts.
The information in this Current Report on Form 8-K (including the
exhibit) is being furnished to Item 7.01 of Form 8-K and shall
not be deemed to be filed for the purpose of Section 18 of the
Securities Exchange Act of 1934, as amended, or otherwise subject
to the liabilities of that section, nor will any of such
information or exhibits be deemed incorporated by reference into
any filing under the Securities Act of 1933, as amended, or the
Securities Exchange Act of 1934, as amended, except as expressly
set forth by specific reference in such filing.
| Item 9.01. | Financial Statements and Exhibits. |
| (d) | Exhibits. | |||
| Exhibit Number | Description | |||
| 99.1 | TherapeuticsMD, Inc. presentation dated January 2017. |
About TherapeuticsMD, Inc. (NYSEMKT:TXMD)
TherapeuticsMD, Inc. is a women’s healthcare product company. The Company’s segment is creating and commercializing products for women. It is focused on conducting clinical trials necessary for regulatory approval and commercialization of advanced hormone therapy pharmaceutical products. Its drug candidates are created using its SYMBODA hormone technology, which enables the administration of hormones with high bioavailability alone or in combination. The Company manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter (OTC) vitamins. The Company’s product line includes vitaTrue, vitaPearl, vitaMedMD Plus, vitaMedMD One Prenatal Multivitamin, vitaMedMD Plus Rx Prenatal Multivitamin, vitaMedMD One Rx Prenatal Multivitamin, vitaMedMD RediChew Rx Prenatal Multivitamin, vitaMedMD Iron 21/7, itaMedMD Menopause Relief with Lifenol Plus Bone Support, vitaMedMD Vitamin D3 50,000 IU, BocaGreenMD Prena1 Pearl and BocaGreenMD Prena1 Chew. TherapeuticsMD, Inc. (NYSEMKT:TXMD) Recent Trading Information
TherapeuticsMD, Inc. (NYSEMKT:TXMD) closed its last trading session down -0.20 at 5.98 with 2,188,277 shares trading hands.
